课题基金 / 基金详情

MUTATIONS OF AN ACTIN BINDING LOOP IN HUMAN NONMUSCLE MYOSIN IIA

MUTATIONS OF AN ACTIN BINDING LOOP IN HUMAN NONMUSCLE MYOSIN IIA
人非肌肉肌球蛋白 IIA 肌动蛋白结合环的突变
批准号:
6162725
负责人:
JAMES R. SELLERS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

JAMES R. SELLERS的其他基金

相似基金

相关文献

中文摘要
翻译
虽然有肌动蛋白和肌凝蛋白晶体,但分子细节
英文摘要
While there are crystals of actin and of myosin, the molecular details of the interaction of myosin with actin are not well understood. There is a biochemical or modeled structural evidence for interaction between several areas of myosin with actin including a myosin surface loop that begins with amino acid 391 and ends with amino acid 404 in the human nonmuscle myosin IIA sequence based upon homology with the chicken skeletal muscle myosin that was crystallized. This loop is postulated to make direct contact with actin based on the Holmes-Rayment-Milligan model for interaction with actin and myosin. In human cardiac myosin, it contains a residue (Arg-403) that is mutated to a Gln or Trp to cause hypertrophic cardiomyopathy (HCM). In Acanthamoeba and Dictyostelium myosin I's and members of the myosin VI class, one of the residues in this loop is invariably a serine or threonine. In the myosin I molecules, phosphorylation of this Thr is required for activity. In almost all other myosins, this residue is either a Glu or Asp, suggesting that a negative charge at this residue is important for activity. We have used site-directed mutagenesis coupled with baculovirus expression of an HMM-like fragment of human nonmuscle IIA. We mutated Arg-393 (equivalent to the HCM mutation in cardiac myosin) to a Gln and Asp-399 (equivalent to the regulatory phosphorylation/invariant negative charged residue) to a Lys. Both mutants and wild-type HMM were well regulated by phosphorylation of the 20 kDa regulatory light chain. The Arg393Gln mutation results in a 25- 50% increase in the Vmax of the actin-activated MgATPase. The mutation did not affect the rate of actin filament sliding in an in vitro motility assay. The Asp399Lys mutation decreased the Vmax by 8-10 fold and the rate of in vitro motility by a factor of two, supporting an important role for the negative charge at this location. Neither mutation had a significant effect on the amount of actin required for half-maximal MgATPase activity and both are well regulated by their 20 kD light chain phosphorylation. We are currently studying other mutations of this loop.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPRESSION OF STUDIES OF MYOSIN V
Studies Of Myosin V
Expression studies of other unconventional myosins
Chemical Inhibitors of Myosin Function
海外基金